PM
BNTX icon

Parametrica Management’s BioNTech BNTX Stock Holding History

Parametrica Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,897
Closed -$5.58M – 83
2021
Q2 		$5.58M Buy
24,897
+16,305
+190% +$3.07M 4.12% 4
2021
Q1 		$897K Sell
8,592
-9,462
-52% -$1M 0.43% 51
2020
Q4 		$1.47M Buy
+18,054
New +$1.77M 0.91% 28

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Parametrica Management's BNTX Position: Q3 2021 in Review

Parametrica Management sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 24,897 shares — an estimated $5.58M sold.

Parametrica Management first reported a position in BNTX in Q4 2020 and held it in 3 quarters. The position peaked at $5.58M in Q2 2021. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Parametrica Management reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Parametrica Management sold 24,897 BioNTech shares in Q3 2021, an estimated $5.58M.
  • Parametrica Management first reported a position in BioNTech in Q4 2020 and held it in 3 quarters.
  • Parametrica Management's BioNTech position peaked at $5.58M in Q2 2021.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Parametrica Management's 13F filing for Q3 2021, filed 12 Nov 2021.